PCSK9 and psoriasis: Recently, expression of PCSK9, a posttranslational regulator of the LDL receptor (LDLR) that leads to LDLR internalization and degradation (3), has been shown to be altered in animal models of psoriasis and in the serum and skin of patients with psoriasis (4, 5).